Elevatus Welath Management »

BioMarin Pharmaceutical shares owned by Elevatus Welath Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Elevatus Welath Management from 13F filings

Historical chart of Elevatus Welath Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Elevatus Welath Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Elevatus Welath Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $412k 7.2k 57.22

More positions owned by Elevatus Welath Management

NVIDIA Corporation (NVDA)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ishares Tr Msci Eafe Etf (EFA)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)
Vaneck Etf Trust Ig Floa Rate Etf (FLTR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Bd Index Fds Short Trm Bond (BSV)

View all positions for Elevatus Welath Management

Top funds holding BioMarin Pharmaceutical

BlackRock
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
Norges Bank Investment Management
Viking Global Investors
State Street Corporation
Vestal Point Capital
AQR Capital Management
FMR
Dimensional Fund Advisors
Geode Capital Management
Capital Research Global Investors
Deep Track Capital

View all funds holding BioMarin Pharmaceutical